- Home
- RVTY
RVTY
Revvity Inc.
as 12-20-2024 3:41pm EST
Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments. First, its diagnostics segment includes immunodiagnostics, reproductive health, and applied genomics. Second, its discovery and analytical solutions is composed of life science, industrial, environmental, and food applications. Revvity offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.
| Founded: | 1937 | Country: | United States |
| Employees: | N/A | City: | WALTHAM |
| Market Cap: | 15.1B | IPO Year: | N/A |
| Target Price: | $129.80 | AVG Volume (30 days): | 955.8K |
| Analyst Decision: | Buy | Number of Analysts: | 15 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 2.06 | EPS Growth: | -65.18 |
| 52 Week Low/High: | $97.32 - $129.50 | Next Earning Date: | 01-30-2025 |
| Revenue: | $2,721,555,000 | Revenue Growth: | -2.66% |
| Revenue Growth (this year): | 2.27% | Revenue Growth (next year): | 5.19% |
Stock Insider Trading Activity of Revvity Inc. (RVTY)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Singh Prahlad R. | RVTY | Please See Remarks | Dec 2 '24 | Sell | $116.38 | 18,365 | $2,134,365.95 | 93,472 | |
| Vohra Tajinder S | RVTY | Please See Remarks | Oct 9 '24 | Sell | $122.14 | 2,154 | $262,201.68 | 19,672 | |
| Vohra Tajinder S | RVTY | Please See Remarks | Oct 7 '24 | Sell | $122.64 | 4,307 | $526,909.86 | 19,672 |
Latest Revvity Inc. News
RVTY Breaking Stock News: Dive into RVTY Ticker-Specific Updates for Smart Investing
Argus Research
5 days ago
RVTY: Lowering target price to $120.00
Business Wire
5 days ago
Revvity to Present at J.P. Morgan Healthcare Conference
Benzinga
9 days ago
Despite Higher Valuations, Some Life Sciences Tools Stocks Create Good Opportunities: Analyst
MT Newswires
9 days ago
BofA Securities Upgrades Revvity to Buy From Neutral
Argus Research
12 days ago
RVTY: Raising target price to $124.00
Simply Wall St.
12 days ago
Can Revvity, Inc. (NYSE:RVTY) Performance Keep Up Given Its Mixed Bag Of Fundamentals?
Zacks
18 days ago
Why Is Revvity (RVTY) Down 8.7% Since Last Earnings Report?
Argus Research
19 days ago
RVTY: What does Argus have to say about RVTY?
Compare RVTY vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "RVTY Revvity Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.